comparemela.com

Latest Breaking News On - Euro average rate - Page 1 : comparemela.com

Johnson & Johnson Reports Q4 and Full-Year 2023 Results

2023 Fourth-Quarter reported sales growth of 7.3% to $21.4 Billion with operational growth of 7.2% and adjusted operational growth of 5.7% . Operational growth excluding COVID-19 Vaccine of.

China
Japan
Johnson-medtech
Joaquin-duato
Ashley-mcevoy
Biosense-webster
Johnson-medtech-acquires-laminar-inc
Exchange-commission
Development-expense
European-medicines-agency
European-medicines-agency-seeking-approval-of-lazertinib
Research-development-expense

Johnson & Johnson : 2023 Third-Quarter Press Release & Supplemental Schedules -October 17, 2023 at 06:45 am EDT

Media contact: Investor contact: .

Joaquin-duato
Tesia-williams
Jessica-moore
European-medicines-agency-seeking-approval
Exchange-commission
Drug-administration-seeking
European-academy-of-dermatology
Finalizes-separation-of-kenvue-inc
Johnson-announces-final-results-of-exchange
Janssen-highlights-latest-research
Consumer-health-company
Trueref-technology-for-mapping

Johnson & Johnson Reports Q3 2023 Results

2023 Third-Quarter reported sales growth of 6.8% to $21.4 Billion with operational growth of 6.4% and adjusted operational growth of 4.9% . Operational growth excluding COVID-19 Vaccine of.

Joaquin-duato
Janssen-to-highlight-latest-research
Finalizes-separation-of-kenvue-inc
Johnson-announces-final-results-of-exchange
Consumer-health
Johnson
European-commission-approves
Interventional-solutions
Company-consumer-health
European-society-of-retina-specialists
Exchange-commission
European-medicines-agency-seeking-approval-of-erdafitinib

Johnson & Johnson Announces Updated Financials and 2023 Guidance Following Completion of the Kenvue Separation

Company expects increased 2023 Reported Sales Growth of 7.0% - 8.0%, Operational Sales Growth of 7.5% - 8.5%, and Adjusted Operational Sales Growth of 6.2% - 7.2%; Figures exclude the COVID-19.

Joaquin-duato
Kenvue-inc
Johnson-consumer-health
Johnson
Abiomed
Consumer-health
Consumer-health-company
Company-consumer-health
Exchange-commission
Chief-executive
Shares-outstanding
Euro-average-rate

Johnson & Johnson : Guidance Press Release with attachments -Today at 09:52 am

FOR IMMEDIATE RELEASE Johnson & Johnson Announces Updated Financials and 2023 Guidance Following Completion of the Kenvue Separation .

Jake-sargent
Joaquin-duato
Jessica-moore
Consumer-health-company
Johnson-consumer-health
Johnson
Kenvue-inc
Consumer-health
Exchange-commission
Company-consumer-health
Johnson-announces-updated-financials
Kenvue-separation

vimarsana © 2020. All Rights Reserved.